Back
Cadence Design Systems Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
62
CDNS
Cadence Design Systems
Last Price:
297.82
Seasonality Move:
4.18%
Buy
97
RYTM
Rhythm Pharmaceuticals
Last Price:
64.04
Seasonality Move:
9.98%
Buy
62
Cadence Design Systems (CDNS)
is a Buy
Is Cadence Design Systems a Buy, Sell or Hold?
- The current Cadence Design Systems [CDNS] share price is $300.90. The Score for CDNS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CDNS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
97
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $65.58. The Score for RYTM is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CDNS Stock Price Chart
What is Cadence Design Systems's stock price today?
-
The Cadence Design Systems share price today is $300.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDNS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $65.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
CDNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.57 | Buy |
| Relative Strength Index (14 RSI): | 65.82 | Buy |
| Chaikin Money Flow: | 967676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (258.1 - 292.16) | Buy |
| Bollinger Bands (100): | (257.48 - 298.9) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.64 | Buy |
| Relative Strength Index (14 RSI): | 75.47 | Buy |
| Chaikin Money Flow: | -747845 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.34 - 58.08) | Buy |
| Bollinger Bands (100): | (43.86 - 53.38) | Buy |
CDNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 292.47 | Buy |
| 20-day SMA: | 275.12 | Buy |
| 50-day SMA: | 270.87 | Buy |
| 200-day SMA: | 288.4 | Buy |
| 8-day EMA: | 292.99 | Buy |
| 20-day EMA: | 282.03 | Buy |
| 50-day EMA: | 275.93 | Buy |
| 200-day EMA: | 276.46 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.17 | Buy |
| 20-day SMA: | 53.22 | Buy |
| 50-day SMA: | 51.3 | Buy |
| 200-day SMA: | 45.17 | Buy |
| 8-day EMA: | 60.15 | Buy |
| 20-day EMA: | 55.23 | Buy |
| 50-day EMA: | 51.77 | Buy |
| 200-day EMA: | 44.82 | Buy |
Cadence Design Systems Earnings Growth & CDNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $0.94 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Cadence Design Systems Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||